Bensalan

This classification denotes an anti-infective agent with the molecular formula C14H10Br3NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 22T0M6CICV, chemically known as 3,5-dibromo-n-(p-bromobenzyl)salicylamide but generally known as bensalan, which bears US NIH Compound Identifier 27449. European Medicines Agency schedules Bensalan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05730MIG. The term BENSALAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 22, No. 10, 1968, List 8). BENSALAN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bensalan under HS 29242995 and SITC 51479. As of Q4 2014, BENSALAN remains the US FDA Preferred Term for this commodity. Bensalan bears US NLM identifiers UMLS ID C2827107 and NCI Concept Code C83604. SMILES: BRC1C(O)C(C(=O)NCC2CCC(BR)CC2)CC(BR)C1.